CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - dyspnoea - Management
Short-acting beta2-agonists: nebules and respules
Age from 16 years onwards
Salbutamol nebules: 2.5mg up to four times a day
Salbutamol 1mg/ml nebuliser liquid 2.5ml unit dose vials
Inhale the contents of one nebule (2.5mg) using the nebuliser up to four times a day, or as directed by your doctor.
Supply 20 2.5ml nebules.
Salbutamol nebules: 5mg up to four times a day
Salbutamol 2mg/ml nebuliser liquid 2.5ml unit dose vials
Inhale the contents of one nebule (5mg) using the nebuliser up to four times a day, or as directed by your doctor.
Supply 20 2.5ml nebules.
Terbutaline respules: 5mg to 10mg up to four times a day
Terbutaline 2.5mg/ml nebuliser liquid 2ml unit dose vials
Inhale the contents of one (5mg) or two (2 x 5mg) respule(s) using the nebuliser up to four times a day, or as directed by your doctor.
Supply 40 2ml respules.
© NHS Institute for Innovation and Improvement